gene_symbol
MS4A1
hgnc_id
HGNC:7315
binding_type
antigen recognition
cytotoxicity
YES
cytotoxicity_type
DIRECT
cytotoxicity_mechanism
After binding CD20, rituximab triggers complement-dependent cytotoxicity and antibody-dependent cellular cytotoxicity (NK cells/macrophages), leading to lysis and clearance of CD20+ B cells.
enzyme_product
Off
epitope
On
variant
Off
isoform
Off
hla_specific
Off
gated
Off
other_modifier
Type I anti-CD20 epitope
trial_id_tar_ref
drug_id_tar_ref
disease_id_tar_ref
nct_id_tar_ref
NCT05786768
disease_id_num_tar_ref
2629
drug_id_num_tar_ref
7012